Skip to results
Modify your search
NARROW
1-20 of 47
Authors: Geert D’Haens
Journal Article
ACCEPTED MANUSCRIPT
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis Get access
Journal of Crohn's and Colitis, jjaf063, https://doi.org/10.1093/ecco-jcc/jjaf063
Published: 17 April 2025
Journal Article
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies
Journal of Crohn's and Colitis, Volume 19, Issue 1, January 2025, jjaf005, https://doi.org/10.1093/ecco-jcc/jjaf005
Published: 13 January 2025
Journal Article
Anti-TNF nonresponse in ulcerative colitis: correcting for mucosal drug exposure reveals distinct cytokine profiles Get access
Journal of Crohn's and Colitis, Volume 19, Issue 1, January 2025, jjae200, https://doi.org/10.1093/ecco-jcc/jjae200
Published: 02 January 2025
Journal Article
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjae164, https://doi.org/10.1093/ecco-jcc/jjae164
Published: 01 November 2024
Journal Article
Outcomes and Endpoints of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Consensus Conference
Journal of Crohn's and Colitis, Volume 18, Issue 6, June 2024, Pages 943–957, https://doi.org/10.1093/ecco-jcc/jjad205
Published: 19 December 2023
Journal Article
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 708–719, https://doi.org/10.1093/ecco-jcc/jjad199
Published: 14 December 2023
Journal Article
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies
Journal of Crohn's and Colitis, Volume 18, Issue 6, June 2024, Pages 818–827, https://doi.org/10.1093/ecco-jcc/jjad206
Published: 09 December 2023
Journal Article
Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes
Journal of Crohn's and Colitis, Volume 18, Issue 4, April 2024, Pages 540–547, https://doi.org/10.1093/ecco-jcc/jjad179
Published: 02 November 2023
Journal Article
Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn’s Disease Patients: A Prospective Open-label Study
Journal of Crohn's and Colitis, Volume 17, Issue 12, December 2023, Pages 1897–1909, https://doi.org/10.1093/ecco-jcc/jjad151
Published: 21 September 2023
Journal Article
Peripheral Blood DNA Methylation Signatures and Response to Tofacitinib in Moderate-to-severe Ulcerative Colitis
Journal of Crohn's and Colitis, Volume 18, Issue 8, August 2024, Pages 1179–1189, https://doi.org/10.1093/ecco-jcc/jjad129
Published: 01 August 2023
Journal Article
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies
Journal of Crohn's and Colitis, Volume 18, Issue 1, January 2024, Pages 134–143, https://doi.org/10.1093/ecco-jcc/jjad118
Published: 12 July 2023
Journal Article
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn’s Disease
Journal of Crohn's and Colitis, Volume 17, Issue 8, August 2023, Pages 1235–1251, https://doi.org/10.1093/ecco-jcc/jjad047
Published: 20 March 2023
Journal Article
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial
Journal of Crohn's and Colitis, Volume 17, Issue 7, July 2023, Pages 1055–1065, https://doi.org/10.1093/ecco-jcc/jjad022
Published: 27 February 2023
Journal Article
Benefit of Risk-stratified Prophylactic Treatment on Clinical Outcome in Postoperative Crohn’s Disease
Journal of Crohn's and Colitis, Volume 17, Issue 3, March 2023, Pages 318–328, https://doi.org/10.1093/ecco-jcc/jjac139
Published: 17 September 2022
Journal Article
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn’s Disease: Meta-Analysis of Randomised Controlled Trials
Journal of Crohn's and Colitis, Volume 16, Issue 5, May 2022, Pages 717–736, https://doi.org/10.1093/ecco-jcc/jjab194
Published: 10 November 2021
Journal Article
A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn’s Disease
Journal of Crohn's and Colitis, Volume 16, Issue 5, May 2022, Pages 746–756, https://doi.org/10.1093/ecco-jcc/jjab201
Published: 10 November 2021
Journal Article
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn’s Disease
Journal of Crohn's and Colitis, Volume 16, Issue 3, March 2022, Pages 444–451, https://doi.org/10.1093/ecco-jcc/jjab161
Published: 16 September 2021
Journal Article
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial
Journal of Crohn's and Colitis, Volume 16, Issue 1, January 2022, Pages 27–38, https://doi.org/10.1093/ecco-jcc/jjab133
Published: 17 August 2021
Journal Article
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis
Journal of Crohn's and Colitis, Volume 16, Issue 2, February 2022, Pages 224–243, https://doi.org/10.1093/ecco-jcc/jjab135
Published: 26 July 2021
Journal Article
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study
Journal of Crohn's and Colitis, Volume 15, Issue 7, July 2021, Pages 1120–1129, https://doi.org/10.1093/ecco-jcc/jjab012
Published: 13 January 2021
